Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) prevents overactivation of the immune system and averts potential damage to the body's own cells.
Programmed Death-1 (PD-1) is a protein that plays a critical role in immune regulation, but can be co-opted by cancer cells to evade the immune...
Nanobody characteristics such as high stability, and specificity have led to their fusion with other proteins for therapeutic and diagnostic purposes.
CD30 is expressed in some tumor cells, making it a potential target for cancer immunotherapy.
In normal cells, HER2 helps to regulate cell growth and division. However, in HER2-positive breast cancer, the cells produce too much of this protein.
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
Checkpoint inhibitors are a form of immunotherapy used to treat cancer.
Whether you're a CRO making customer deliveries, a start-up advancing towards IND, or an established biopharma supporting multiple programs at once, Affinity supports every team, at every step, on a single platform, for a single price.